Acadia Pharmaceuticals Inc (ACAD)

Cash & Short-Term Investments

$956.47M

Quarterly · Period ending: · USD

ACAD logo

ACAD Cash & Short-Term Investments

Latest reported$956.47M
ACAD Quarterly Cash & Short-Term Investments ($27.21M → $956.47M)
High-resolution chart · PNG

ACAD cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Acadia Pharmaceuticals Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
956,474,000
851,458,000
819,686,000
847,019,000
761,996,000
681,577,000
755,993,000
565,330,000
500,942,000
470,520,000
438,865,000
345,920,000
375,378,000
402,873,000
416,823,000
436,579,000
436,351,000
445,977,000
520,706,000
540,291,000
556,918,000
577,768,000
631,958,000
644,441,000
658,551,000
651,406,000
697,429,000
683,847,000
381,887,000
414,324,000
473,520,000
214,136,000
256,855,000
298,063,000
341,342,000
366,625,000
417,320,000
469,481,000
529,036,000
588,859,000
412,555,000
457,243,000
215,132,000
240,691,000
270,777,000
297,893,000
322,486,000
337,799,000
354,453,000
369,285,000
185,790,000
196,180,000
205,451,000
101,463,000
107,967,000
23,058,000
21,349,000
25,924,000
31,048,000
36,150,000
40,361,000
45,664,000
37,087,000
32,226,000
34,275,000
40,576,000
47,060,000
54,909,000
66,152,000
46,384,000
60,083,000
72,698,000
89,621,000
106,499,000
126,858,000
140,962,000
153,869,000
69,899,000
83,255,000
94,657,000
94,135,000
43,684,000
43,001,000
62,731,100
68,960,800
41,646,100
35,927,400
43,157,800
48,792,700
22,494,100
27,214,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.